|
advertisement
|
|
|
| Journal Articles Details
|
|
More October, 2004 pharmacogenomics journal articles.- Pharmacogenomics of adrenoceptors.
by Flordellis C, Paris H, Karabinis A, Lymperopoulos A.
Journal: Pharmacogenomics. 5(7):803-17
- Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
by Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Mukit SR, Shriharsh V, Lerer B, Nimagaonkar VL, Thelma BK.
Journal: Pharmacogenomics J. 10 2004;:
- Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
by Liljedahl U, Lind L, Kurland L, Berglund L, Kahan T, Syvänen AC.
Journal: BMC Cardiovasc Disord. 09 2004;4(1):16
- Individual response to treatment: is it a valid assumption?
by Senn S.
Journal: BMJ. 329(7472):966-8
- Will tomorrow's medicines work for everyone?
by Tate SK, Goldstein DB.
Journal: Nat Genet. 36(11 Suppl):S34-42
- Optimized antiretroviral therapy: the role of therapeutic drug monitoring and pharmacogenomics.
by van Heeswijk RP.
Journal: Expert Rev Anti Infect Ther. 1(1):75-81
- Genetic determinants of platelet function in thromboembolic diseases.
by Corral J, González-Conejero R, Vicente V.
Journal: J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):166-71
- Genetic association studies in epilepsy: "the truth is out there".
by Tan NC, Mulley JC, Berkovic SF.
Journal: Epilepsia. 45(11):1429-42
- Genetic testing in primary care.
by Burke W.
Journal: Annu Rev Genomics Hum Genet. 5:1-14
- Microarrays in pharmacogenomics.
by Chen JJ.
Journal: J Biopharm Stat. 14(3):535-7
- Clinical and functional consequences of platelet membrane glycoprotein polymorphisms.
by Yee DL, Bray PF.
Journal: Semin Thromb Hemost. 30(5):591-600
- Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
by Dimitrova A, Milanova V, Krastev S, Nikolov I, Toncheva D, Owen MJ, Kirov G.
Journal: Pharmacogenomics J. 10 2004;:
- Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.
by Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC, Curry SJ, McAfee T.
Journal: Pharmacogenomics J. 10 2004;:
- Genotyping technologies: application to biotransformation enzyme genetic polymorphism screening.
by Romkes M, Buch SC.
Journal: Methods Mol Biol. 291:399-414
- [ASCO Annual Meeting 2004, New Orleans. Therapeutic options in colorectal cancer]
by Longo F, Mansueto G.
Journal: Tumori. 2004 Jul-Aug;90(4):13-27
- Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
by Serretti A, Zanardi R, Franchini L, Artioli P, Dotoli D, Pirovano A, Smeraldi E.
Journal: Pharmacogenetics. 14(9):607-13
- Pharmacogenetics of methotrexate.
by Krajinovic M, Moghrabi A.
Journal: Pharmacogenomics. 5(7):819-34
- Toward the pharmacogenomics of cystic fibrosis - an update.
by Sangiuolo F, D'Apice MR, Gambardella S, Di Daniele N, Novelli G.
Journal: Pharmacogenomics. 5(7):861-78
- How molecular medicine transforms policy (and everything else).
by Kean MA, Batchelder KF.
Journal: J Biolaw Bus. 7(3):16-9
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|